Tretinoin NDC 70518-3233

NDC codes

FDA NDC Directory

Product NDC (as listed)70518-3233Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70518-3233Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70518-3233-0	70518323300	1 TUBE in 1 CARTON (70518-3233-0) / 20 g in 1 TUBEMarketed from Oct 11, 2021

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tretinoin
Generic name (nonproprietary): tretinoin
Active ingredients: Tretinoin — 1 mg/g
Dosage form: Cream
Route: Topical
Labeler: REMEDYREPACK INC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075213
Marketing start: Oct 11, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Retinoids (Chemical structure)
Identifiers: Product ID 70518-3233_4ede161d-daeb-d892-e063-6294a90a7487SPL ID 4ede161d-daeb-d892-e063-6294a90a7487SPL set ID c4d5155b-046d-4f94-bafc-651b572c2bd5RxCUI 198300UNII 5688UTC01R
Pharmacologic class: Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518323300 followed by a unit qualifier and the quantity

Package 70518-3233-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 7, 2026.

Indications (excerpt from the label)

Indications and Usage: Tretinoin gel and cream are indicated for topical application in the treatment of acne vulgaris. The safety and efficacy of the long-term use of this product in the treatment of other disorders have not been established.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 075213

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075213
Product	Strength	Form · route	Labeler	Product NDC
Tretinoin	Tretinoin 1 mg/g	CreamTopical	Padagis US LLC	0574-2201